Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers

被引：0
|
作者：
Wei Zhang
Junping Shi
Yingying Wang
Hongyuan Zhou
Zewu Zhang
Zhiqiang Han
Guanghao Li
Bo Yang
Guangtai Cao
Yan Ke
Ti Zhang
Tianqiang Song
机构：
[1] Tianjin Medical University Cancer Institute and Hospital,Department of Hepatobiliary Cancer
[2] OrigiMed,Department of Pathology
[3] Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy
[4] Tianjin’s Clinical Research Center for Cancer,undefined
来源：
Cancer Immunology, Immunotherapy | 2021年 / 70卷
关键词：
Biliary tract cancer; Next-generation sequencing; Immunotherapy; Targeted therapy; Personalized medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1001 / 1014
页数：13
相关论文
共 50 条
  • [41] Targeted next-generation sequencing in monogenic dyslipidemias
    Hegele, Robert A.
    Ban, Matthew R.
    Cao, Henian
    McIntyre, Adam D.
    Robinson, John F.
    Wang, Jian
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (02) : 103 - 113
  • [42] Next-Generation Sequencing: Targeting Targeted Therapies
    McCutcheon, Justine N.
    Giaccone, Giuseppe
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3584 - 3585
  • [43] The choice for the optimal therapy in advanced biliary tract cancers: Chemotherapy, targeted therapies or immunotherapy
    Palmieri, Lola-Jade
    Lavol, J.
    Dermine, S.
    Brezault, C.
    Dhooge, M.
    Barr, A.
    Chaussade, S.
    Coriat, R.
    PHARMACOLOGY & THERAPEUTICS, 2020, 210
  • [44] Targeted Next-Generation Sequencing Reveals High Mutational Burden in Aggressive Thyroid Cancers
    Kleinlein, Irene
    Pfarr, Nicole
    Haller, Bernhard
    Keller, Gisela
    Fuerst, Heinrich
    Weichert, Wilko
    Kremer, Marcus
    MODERN PATHOLOGY, 2018, 31 : 232 - 233
  • [45] Targeted Next-Generation Sequencing Reveals High Mutational Burden in Aggressive Thyroid Cancers
    Kleinlein, Irene
    Pfarr, Nicole
    Haller, Bernhard
    Keller, Gisela
    Fuerst, Heinrich
    Weichert, Wilko
    Kremer, Marcus
    LABORATORY INVESTIGATION, 2018, 98 : 232 - 233
  • [46] THE POTENTIAL OF MOLECULAR-TARGETED THERAPY WITH EGFR AND VEGFR SIGNALING INHIBITORS AGAINST BILIARY TRACT CANCER
    Yoshikawa, D.
    Ojima, H.
    Kosuge, T.
    Kono, T.
    Furukawa, H.
    Shibata, T.
    ANNALS OF ONCOLOGY, 2010, 21 : 51 - 52
  • [47] Targeted Cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers
    Christakis, Alexander G.
    Papke, David J.
    Nowak, Jonathan A.
    Yurgelun, Matthew B.
    Agoston, Agoston T.
    Lindeman, Neal I.
    MacConaill, Laura E.
    Sholl, Lynette M.
    Dong, Fei
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (07) : 1246 - 1251
  • [48] Utility of Targeted Next-Generation Sequencing Assays in a Routine Molecular Pathology Laboratory
    Cong, L.
    Zhang, J.
    Sipley, J.
    Ruggiero, P.
    Fernandes, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 851 - 851
  • [49] Targeted Next-Generation Sequencing in the Molecular Profiling of Lower-Grade Gliomas
    Carter, Jamal H.
    Cottrell, Catherine E.
    Duncavage, Eric J.
    LABORATORY INVESTIGATION, 2016, 96 : 429A - 429A
  • [50] Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma
    Lucas, Calixto-Hope G.
    Grenert, James P.
    Horvai, Andrew
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (08) : 1009 - 1017
12345